Viller Tuxen, Ida
Barlebo Ahlborn, Lise
Mau-Soerensen, Morten
Staal Rohrberg, Kristoffer
Cilius Nielsen, Finn
Oestrup, Olga
Westmose Yde, Christina
Richter Vogelius, Ivan
Lassen, Ulrik
Article History
Received: 26 November 2018
Revised: 9 May 2019
Accepted: 16 May 2019
First Online: 12 June 2019
Competing interests
: M.M-S. has received lecture honoraria and support to participate in the scientific conference from Roche. K.S.R. received support to participate in the scientific conference from Roche and Sanofi. The remaining authors declare no competing interests.
: Regulatory approvals from the Regional Ethics Committee and the Danish Data Protection Agency were obtained (Danish Ethical Committee, file number: 1300530). All patients provided signed informed consent and the study was performed in accordance with the Declaration of Helsinki.
: We thank the Capital Region of Copenhagen and the Oncological Research Fund, Department of Oncology, Copenhagen University Hospital, Denmark for financial support.
: Data is available as Supplementary material. An interactive version of the prognostic model is published on ExternalRef removed
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).